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Objective: Endothelial cell migration is inhibited by oxidized low-density lipoprotein (oxLDL) and lysophosphatidylcho-
line (lysoPC). The purpose of this study was to explore the mechanism of this inhibition, specifically the role of reactive
oxygen species.
Methods: The ability of oxLDL, lysoPC, and known superoxide generators to stimulate endothelial cell production of
reactive oxygen species and inhibit endothelial cell migration under the same conditions was assessed. Reactive oxygen
species production was assessed with dichlorofluorescein. Migration was studied with a razor scrape assay and measured
after 24 hours. In addition, the ability of various antioxidants, added before initiation of the scrape assay, to restore
endothelial cell migration in oxLDL was determined.
Results: OxLDL and lysoPC, at concentrations that stimulated reactive oxygen species production, also inhibited
endothelial cell migration. Other agents that generated superoxide also inhibited endothelial cell migration, but
hydrogen peroxide did not. Of a variety of antioxidants assessed for their ability to preserve endothelial cell migration in
the presence of oxLDL, only superoxide dismutase and reduced nicotinamide adenine dinucleotide (phosphate) oxidase
inhibitors (diphenyleneiodonium, quinacrine, hydralazine) preserved endothelial cell migration.
Conclusions: These data suggest that oxLDL inhibits endothelial cell migration through a superoxide-dependent
mechanism and that reduced nicotinamide adenine dinucleotide (phosphate) oxidase is the cellular source of the
superoxide.
Clinical Relevance: OxLDL inhibits endothelial cell migration, and may impair healing of arterial injuries. The
mechanism of oxidized LDL inhibition is not known. Our in vitro studies show that the inhibitory properties are related
to production of reactive oxygen species. Superoxide dismutase or inhibitors of reduced nicotinamide adenine dinucle-
otide phosphate oxidase can preserve endothelial migration in the presence of oxLDL. This might improve the healing of
endothelial injuries at sites of arterial repair or angioplasty, especially in lipid-laden arterial walls. ( J Vasc Surg 2004;40:
1208-15.)Endothelial cell migration is central to many physio-
logic and pathologic processes, including angiogenesis,
repair of arterial injuries, and vascular graft healing. De-
layed reendothelialization after angioplasty is thought to
contribute to recurrent stenosis. Failure of prosthetic grafts
to endothelialize leads to continued thrombogenicity of
the luminal surface, and may contribute to late graft failure.
In human beings endothelial cells migrate only 1 to 2 cm
onto prosthetic grafts from the anastomosis, but factors
responsible for the limited endothelial cell migration onto
grafts are not clearly defined. Lipids accumulate in pros-
thetic grafts, particularly adjacent to the anastomosis,1,2
and may account for the limited endothelial cell migration.
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1208Hypercholesterolemia is a risk factor for angioplasty or
vascular graft failure, just as it is for atherosclerosis. Li-
poproteins concentrate in areas of arterial injury,3 and lipid
oxidation products accumulate in prosthetic grafts.4 Oxi-
datively modified lipids and lipoproteins may have a role in
recurrent stenosis after angioplasty and vascular graft fail-
ure, because oxidized low-density lipoproteins (oxLDL)
possess a number of properties that would adversely affect
healing, including inhibition of endothelial cell migration.5
We have shown that Dacron graft material activates mono-
cytic cells to oxidize low-density lipoprotein (LDL),6 and
that cell-modified LDL inhibits endothelial cell migration.7
The mechanism by which oxLDL inhibits endothelial
cell migration is an area of active investigation. OxLDL
increases intracellular formation of reactive oxygen species
in endothelial cells and arterial wall segments.8,9 In addi-
tion, aortic production of superoxide (O2
) is increased in
rabbits with hypercholesterolemia.10,11 Since reactive oxy-
gen species can affect a variety of cell functions, we explored
their role in the inhibition of endothelial cell migration by
oxLDL. OxLDL and lysophosphatidylcholine (lysoPC), a
major lipid component of oxLDL, stimulated reactive ox-
ygen species production and inhibited endothelial cell mi-
gration. Redox cycling naphthoquinones that produce
O2
 also inhibited EC migration. Superoxide dismutase
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 production by reduced nicotinamide
adenine dinucleotide (phosphate) (NAD[P]H) oxidase
preserved endothelial cell migration in the presence of
oxLDL.
MATERIAL AND METHODS
Cell culture. Endothelial cells were isolated from
adult bovine aortas as previously described,12 and subcul-
tured in Dulbecco modified Eagle medium and Ham F-12
nutrient mixture (DMEM/F-12; 1:1 vol/vol; Invitrogen)
containing 5% fetal calf serum (Hyclone Laboratories).
Endothelial cells were maintained at 37°C in a humidified
atmosphere containing 5% CO2, and used between pas-
sages 5 and 20.
Preparation and modification of lipoproteins.
Human LDL (d  1.019-1.063) was isolated from fresh,
single-donor, citrated normolipemic plasma containing
ethylenediamine tetraacetic acid (EDTA), with sequential
ultracentrifugation.13,14 The purity was assessed with aga-
rose gel electrophoresis, and homogeneity of the LDL was
confirmed by the presence of a single band on the gel.13 All
preparations were assayed for protein,15 total cholesterol
(BoehringerMannheim), endotoxin (Pierce Chemical Co),
and thiobarbituric acid reactive substances (TBARS).
LDL was oxidized with CuSO4. LDL was dialyzed
against 0.9% saline solution at 4°C for 48 hours to remove
the EDTA. The LDL (concentration of 5-8 mg of choles-
terol/mL) was then incubated with 1 mol/L CuSO4 for
16 to 23 hours at 37°C. Oxidation was quenched by
addition of 5 mol/L of EDTA. The supernatant was
collected and analyzed for cholesterol with cholesterol cal-
ibrators (Sigma). As a measure of lipid oxidation, TBARS
were measured with the method of Schuh et al.16 Samples
were analyzed with a fluorimeter, with excitation at 515 nm
and emission at 553 nm. TBARS were expressed as nano-
moles of malondialdehyde per milligram of cholesterol.
Measurement of reactive oxygen species generation.
Reactive oxygen species production by endothelial cells was
assessed with 5 (and 6)-chloromethyl-2’,7’-dichlorofluo-
rescein (DCF;Molecular Probes) as previously described.17
Endothelial cells were cultured in 12-well plates in
DMEM/F-12 with 10% serum, then made quiescent over-
night in serum-free DMEM. Endothelial cells were incu-
bated with 2’,7’-DCF diacetate (10 mol/L) for 30 min-
utes to load cells. Agonists were added to the endothelial
cells, and the plates were incubated at 37°C for 3 hours.
DCF fluorescence at an excitatory wavelength of 480 nm
was visualized with a Leica DM IRB inverted fluorescent
microscope coupled with a digital imaging system. Fluores-
cence images (1300  1030 pixels) were captured in a
minimum of 3 randomly selected locations in each well.
Measurement of endothelial cell migration.
Endothelial cell migration was measured with the razor
scrape assay, as previously described.5,18 In brief, confluent
endothelial cell monolayers in 12-well tissue culture plates
were made quiescent by replacing the medium with serum-
free DMEM containing 1 mg/mL of gelatin for 24 hours
before use. A razor blade was pressed through the endo-thelial cell monolayer into the plastic plate to mark the
starting line. Endothelial cells were swept away on one side
of that line. Endothelial cells were washed, and 1.0 mL of
Roswell ParkMemorial Institute (RPMI) medium contain-
ing gelatin (1 mg/mL) and the test substance was added.
Migration was stopped after 24 hours by fixing and staining
with modified Wright-Giemsa stain. A 256-gy level, 640
480-pixel image of migrating cells was captured with a
digital charged couple device camera mounted on a phase-
contrast microscope. Image analysis was performed with
the Image software package (provided by Dr Wayne Ras-
band, National Institutes of Health). In each well, images
of 2 random fields, each consisting of 1500 m length of
wound, were captured, and the number of cells that crossed
the starting line was determined. All experiments were
performed in triplicate, on at least 2 different cell isolates
with different LDL preparations. Data are expressed as
mean number of cells across 3000 m of starting line at 24
hours plus or minus the standard error of the mean (SEM).
Cell treatment. The role of reactive oxygen species in
the inhibition of endothelial cell migration by oxLDL and
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (lyso
PC; Avanti Polar Lipids) was investigated with antioxidants
with various mechanisms of action. The concentrations
used were based on published studies. The ability of 50 to
150 U/mL of superoxide dismutase (Sigma) to preserve
endothelial cell migration in oxLDL or lysoPC was as-
Fig 1. Agonist-induced reactive oxygen species production par-
alleled inhibition of endothelial cell migration.A, Reactive oxygen
species generation was determined with fluorescence microscopy
(see Methods). Representative results of 1 of 3 separate experi-
ments are shown. B, In parallel studies, endothelial cell migration
was assessed with the razor scrape assay. Migration was stopped at
24 hours by fixing cells with Wright-Giemsa stain. Arrow indicates
starting line for migration. Substances tested included culture
medium, oxidized low-density lipoprotein (oxLDL; 400 g cho-
lesterol/mL), lysophosphatidyl phosphatidylcholine (lysoPC, 10
mol/L), 6-anilinoquinoline-5,8,quinone (LY83583, 2.5 mol/
L), or 2,3-dimethoxy-1,4-naphthoquinone (DMNQ, 7.5 mol/
L). LDL, Low-density lipoprotein.sessed.19 The effect of 300 U/mL of catalase (Sigma), an
n in b
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tested.19Mannitol (10mmol/L; Sigma), a hydroxyl radical
scavenger, and glutathione (1 mmol/L; Sigma) were stud-
ied.20,21 Additional studies were undertaken with inhibi-
tors of O2
 production to assess the cellular source of the
O2
. Experiments used inhibitors of cyclooxygenase (1-10
mol/L of indomethacin; Sigma),22 xanthine oxidase (10-
200 mol/L of allopurinol; Sigma),23 and NAD(P)H ox-
idase [0.5-2.0 mol/L of diphenylene iodonium (DPI;
Sigma; 0.5-1.0 mol/L of quinacrine; Sigma; and 10-50
mol/L of hydralzine; Sigma].24-27 The effect of these
agents on reactive oxygen species production and endothe-
lial cell migration in the presence or absence of oxLDL was
Fig 2. Superoxide dismutase (SOD) preserved migrati
lipoprotein (oxLDL) or lysophosphtidyl phosphatidylch
determined as described (see Methods). SOD was add
separate experiments are shown. B, Endothelial cells wer
U/mL) for 1 hour. Migration assay was initiated, the
Endothelial cells were allowed to migrate for 24 hours,
Giemsa stain.C,Number of endothelial cells (EC) crossi
of SOD to decrease lysoPC-induced reactive oxygen spe
of SOD (50U/mL) to preserve endothelial cell migratio
hours was quantitated with image analysis. *P  .05 vs m
endothelial cell migration with or without SOD is showassessed.Statistics. All data representmean SEM.Experiments
were performed in triplicate with at least 2 different cell
isolates. Data evaluation was performed with the t test or
analysis of variance with GraphPad InStat software. Differ-
ences were considered statistically significant at P .05.
RESULTS
Reactive oxygen species production and endothelial
cell migration. OxLDL increases reactive oxygen species
production by endothelial cells,8 and O2
 may inhibit
endothelial cell migration. Therefore the ability of oxLDL,
lysoPC, and known O2
 generators to stimulate endothe-
lial cell production of reactive oxygen species and inhibit
endothelial cells incubated with oxidized low-density
(lysoPC). A, Reactive oxygen species generation was
fore the agonists indicated. Representative results of 3
wn to confluence, then incubated with SOD (0, 50, 150
D and oxLDL (400 g cholesterol/mL) were added.
migration was terminated by fixing cells with Wright-
rting line was quantitated with image analysis.D, Ability
roduction was assessed as described. E, Similarly, ability
soPC (5 or 10 mol/L) was studied. F,Migration at 24
m, **P  .01 vs medium. Statistical difference between
oxed insets.on of
oline
ed be
e gro
n SO
then
ng sta
cies p
n in ly
ediuendothelial cell migration under the same conditions was
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increase in reactive oxygen species production over endo-
thelial cells in medium alone. OxLDL (TBARS ranging
from 6.2-9.6 nmol of malondialdehyde per milligram of
cholesterol) and lysoPC treatment of endothelial cell
monolayers resulted in increased reactive oxygen species
production (Fig 1, A). In addition, 6-anilinoquinoline-
5,8,quinone (LY83583; Sigma), a superoxide-generating
quinone, and 2,3-dimethoxy-1,4-naphthoquinone
(DMNQ), a redox cycling quinone that generates superox-
ide and H2O2 through 1-electron and 2-electron reduc-
tions, caused an increase in reactive oxygen species produc-
tion by endothelial cells (Fig 1, A). To explore the
relationship between reactive oxygen species production
and inhibition of endothelial cell migration, the effect
oxLDL, lysoPC, LY83583, andDMNQon endothelial cell
migration was assessed. The agents that stimulated reactive
oxygen species production also inhibited endothelial cell
migration (Fig 1, B). Because H2O2 is also produced by the
naphthoquinones, we assessed the effect of H2O2 added to
endothelial cells immediately after the razor scrape in the
migration assay. H2O2 (10-50 mol/L) had no effect on
endothelial cell migration, and higher concentrations
(100 mol/L) caused cells to lift from the plates (data
not shown). These data suggest that stimulation of O2

production, not H2O2, might be responsible for inhibition
of endothelial cell migration.
Effect of reactive oxygen species scavengers and
antioxidants on endothelial cell migration. If O2
 in-
hibits migration, superoxide dismutase should preserve en-
dothelial cell migration in the presence of oxLDL. Super-
oxide dismutase decreased oxLDL-induced reactive
oxygen species production by endothelial cells (Fig 2, A)
and preserved endothelial cell migration in the presence of
oxLDL concentrations that alone would be inhibitory (Fig
2, B and C). In fact, superoxide dismutase restored endo-
thelial cell migration in oxLDL to the same level as migra-
tion in LDL, which typically is slightly increased compared
with medium alone. Similarly, superoxide dismutase (50
U/mL) was also capable of decreasing lysoPC-induced
reactive oxygen species production (Fig 2, D) and protect-
ing migration in the presence of lysoPC (Fig 2, E and F).
Superoxide dismutase (50 and 150 U/mL) alone did not
alter endothelial cell migration when compared with me-
dium alone (results not shown). Hydroxythiourea, a com-
pound that scavenges both O2
 and the hydroxyl radical
(OH), also protected endothelial cell migration in the
presence of oxLDL (results not shown). This raised the
possibility that other reactive oxygen species, especially
OH,might contribute to the inhibition of endothelial cell
migration by oxLDL. Consequently, the effect of mannitol
(10 mmol/L) and glutathione (1 mmol/L) were tested
(Fig 3). Neither preserved endothelial cell migration in the
presence of oxLDL. Catalase, an enzymatic scavenger of
H2O2, was also ineffective in restoring endothelial cell
migration (Fig 3). These data suggest that the mechanism
by which oxLDL inhibits endothelial cell migration does
not involve OH or H2O2.Source of superoxide. The source of O2
 production
during incubation of endothelial cells with oxLDL was
investigated with inhibitors of superoxide-generating en-
zymes. Indomethacin, a cyclooxygenase inhibitor, and al-
lopurinol, a xanthine oxidase inhibitor, did not preserve
endothelial cell migration in the presence of oxLDL (Fig 4,
A and B), which suggests that neither of these enzymatic
systems is responsible for the O2
 generated by endothelial
cells exposed to oxLDL. Several NAD(P)H oxidase inhib-
itors, including DPI, quinacrine, and hydralazine, were
tested. These 3 compounds inhibited the production of
reactive oxygen species and preserved endothelial cell mi-
gration in the presence of oxLDL (Fig 5). When endothe-
lial cell monolayers were exposed to effective concentra-
tions of these agents in the absence of oxLDL, then
subjected to razor scrape, no change in basal endothelial
cell migration was observed. These data suggest that
NAD(P)H oxidase was the source of O2
 generated by
endothelial cells incubated with oxLDL.
DISCUSSION
Endothelial cell migration is a critical component of
arterial wall “wound healing” after endothelial denudation
that occurs during interventions such as angioplasty. How-
ever, the same lipid oxidation products that accumulate in
atherosclerotic lesions and prosthetic grafts in vivo inhibit
endothelial cell migration in vitro. The ability of oxLDL to
inhibit endothelial cell migration is well documented, and
much of the inhibitory activity is attributed to lysoPC, a
product of lipid oxidation.5,28 The mechanism by which
oxLDL and lysoPC inhibit endothelial cell migration is
unclear. This study was undertaken to gain insight into that
mechanism, the knowledge of which might suggest thera-
peutic interventions to preserve migration.
OxLDL causes oxidative stress that leads to increased
production of reactive oxygen species by endothelial cells,8
and this could be related to the inhibitory effect of oxLDL.
Although there is some discrepancy in the literature as to
Fig 3. Scavengers of OH and hydrogen peroxide failed to pre-
serve migration in presence of oxidized low-density lipoprotein
(oxLDL). Confluent monolayers of endothelial cells were incu-
bated for 1 hour with mannitol (10 mmol/L), glutathione (1
mmol/L), or catalase (300 U/mL); then razor scrape was per-
formed. Endothelial cells were washed and oxLDL (400 g cho-
lesterol/mL), and mannitol, glutathione, or catalase was again
added. Migration was terminated after 24 hours with Wright-
Giemsa stain. LDL, Low-density lipoprotein.the ability of lysoPC to stimulate O2
 production by en-
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endothelial cell production of O2
.30,31 Our studies dem-
onstrate that both oxLDL and lysoPC stimulate reactive
oxygen species production by endothelial cells, and both
inhibit endothelial cell migration. OxLDL and lysoPC in-
duce lectin-like oxLDL receptor-1 expression,32 and bind-
ing of oxLDL to lectin-like oxLDL receptor-1 increases
reactive oxygen species production.33 We also show that
other agents that increase reactive oxygen species produc-
tion inhibit endothelial cell migration. Thus reactive oxy-
gen species may be the mechanism by which oxLDL arrests
endothelial cell migration.
The amount or duration of reactive oxygen species
formation may influence its effect on endothelial cell mi-
gration. Moldovan et al34 report that reactive oxygen spe-
cies production by endothelial cells at the margin of a
wound is necessary for migration, and application of a
superoxide dismutase mimetic or an inhibitor of NAD(P)H
oxidase (DPI) limits endothelial cell migration. They sug-
gest that loss of confluence causes an increase in intracellu-
lar reactive oxygen species that contributes to cytoskeletal
reorganization required for migration. In fact, coupling of
tyrosine kinase and O2
-producing pathways are required
for actin polymerization.35 Excessive O2
 production,
however, may abolish endothelial cell migration through
excessive cytoskeletal disruption, as is suggested by the
rounded appearance of the endothelial cells after exposure
to inhibitory concentrations of oxLDL or lysoPC in our
studies (data not shown). Furthermore, increased O2

production may lead to formation of high levels of per-
oxynitrite, which has been reported to inhibit actin poly-
merization and impair neutrophil chemotaxis and fibroblast
migration.36,37 Thus, while physiologic production of
O2
, subject to feedback attenuation, is necessary for mi-
gration, a pathologic level of O2
 production inhibits
movement.
Generation of small amounts of reactive oxygen species
or reactive nitrogen species is essential for normal cell
Fig 4. Cyclooxygenase and xanthine oxidase inhibito
low-density lipoprotein (oxLDL). A, Indomethacin,
monolayers of endothelial cells (EC) for 1 hour. Migratio
cholesterol/mL) and the inhibitor were added. Endothe
terminated with addition of Wright-Giemsa stain, and nu
analysis. B, Effect of allopurinol, a xanthine oxidase inhib
 .05 vs medium, **P  .01 vs medium.function, but hypercholesterolemia induces increased reac-tive oxygen species production. A single source for the
lipid-induced O2
 production is not clearly identified in
the literature. Evidence suggests that NAD(P)H oxidases
are activated by hypercholesterolemia or injury to the arte-
rial wall,38-40 but other reports suggest that chronic hyper-
cholesterolemia increases O2
 production by activation of
xanthine oxidase, because it is inhibited by oxypurinol.11,41
Oxypurinol, however, also has hydroxyl radical scavenging
properties.42 Our in vitro studies and those of others43,44
support NAD(P)H oxidases as the source of O2
 in endo-
thelial cells exposed to oxLDL. In addition, we show that
NAD(P)H oxidase inhibitors, but not xanthine oxidase
inhibitors, preserve endothelial cell migration in the pres-
ence of oxLDL. Thus it appears that hypercholesterolemia
or exposure to oxidatively modified lipids or lipoproteins,
such as those contained in atherosclerotic plaque, induces
increased endothelial NAD(P)H oxidase-generated O2
,
which may be sufficient to inhibit endothelial cell migra-
tion.
The findings that oxLDL stimulates NAD(P)H oxidase
production of O2
 and that reactive oxygen species inhibit
endothelial cell migration has direct clinical relevance. Hy-
percholesterolemia increases O2
 production in intact ves-
sels, and this may adversely affect migration in areas of
endothelial cell injury that result from angioplasty or sur-
gery of atherosclerotic arteries. Of interest, balloon injury
itself causes oxidative stress.45,46 NAD(P)H oxidase activ-
ity is increased after balloon injury to porcine coronary
arteries, with elevated O2
 production detected within 24
hours.40 O2
 production by injured vessels continues to be
elevated 14 days after injury.46 O2
 production is also
higher in vein grafts than in arterial grafts.47 DPI, but not
inhibitors of other oxidant enzymes, abolishes the elevated
O2
 production by vein grafts, which suggests that
NAD(P)H oxidases are responsible.47 These studies, to-
gether with our findings, suggest that O2
 production is
elevated in the same areas where endothelial cell migration
is required to heal injuries, and may impede healing of
not preserve endothelial cell migration in oxidized
looxygenase inhibitor, was incubated with confluent
s initiated in the razor scrape assay, and oxLDL (400 g
lls were allowed to migrate for 24 hours. Migration was
of cells crossing starting line was quantitated with image
n endothelial cell migration in oxLDL, was assessed. *Prs did
a cyc
n wa
lial ce
mber
itor oangioplasty sites or vein grafts where the endothelial cell
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 6 van Aalst et al 1213monolayer has been disrupted. This impaired endothelial
cell healing may enable prolonged smooth muscle cell
proliferation, cause increased intimal thickening, and de-
crease compensatory remodeling.48 In fact, Huynh et al49
demonstrated that intraoperative superoxide dismutase
treatment decreases intimal hyperplasia in vein grafts,
which suggests that O2
 adversely affects vein graft heal-
ing, perhaps by inhibiting endothelial cell migration. Sim-
ilarly, increased superoxide dismutase expression by gene
transfer to the balloon-injured aortic wall in rabbits results
in more rapid reendothelialization and reduced intimal
hyperplasia.50 Although NAD(P)H oxidase inhibitors pre-
serve endothelial cell migration in vitro, their efficacy in
promoting the healing of arterial injuries or vascular grafts
in vivo remains to be determined.
In summary, we present evidence that oxLDL inhibits
endothelial cell migration in part by stimulating reactive
oxygen species production, which in turn inhibits cell
movement. Impaired endothelial cell migration may be an
important clinical problem, especially in patients with hy-
percholesterolemia or easily oxidized lipids and lipopro-
teins who are undergoing vascular interventions such as
angioplasty. The finding that oxLDL-induced reactive ox-
Fig 5. Reduced nicotinamide adenine dinucleotide (ph
cell production of reactive oxygen species and preserved
(oxLDL). A, Endothelial cells were made quiescent o
quinacrine (Q, 1 mol/L), or hydralazine (Hyd, 25 m
added for 30 minutes, then endothelial cells were inc
generation was assessed with fluorescence microscopy. R
B, In parallel studies, migration was assessed after endo
inhibitors for 1 hour. After razor scrape, NAD(P)H
cholesterol/mL).Migration was stopped at 24 hours with
analysis. *P  .05 vs medium, **P  .01 vs medium.ygen species production retards endothelial cell migrationsuggests that aggressive correction of lipid abnormalities, in
combination with dietary antioxidants or systemic or local
therapeutic agents, such as NAD(P)H oxidase inhibitors,
may promote reendothelialization after arterial interven-
tions. Although antioxidants may be useful to retard lipid
oxidation and preserve cell function, inhibition of all reac-
tive oxygen species production might not accelerate endo-
thelial cell healing of arterial injuries, because low levels of
reactive oxygen species are required for endothelial cell
migration.34 Cell-specific or region-specific delivery of an-
tioxidants may be necessary to maximize beneficial effects.
Identifying the mechanism by which reactive oxygen spe-
cies inhibit migration may enable more directed interven-
tions to restore endothelial cell migration and promote
healing of angioplasty sites and vein grafts.
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